sulfacetamide sodium 98 MG/ML Topical Foam [Ovace]

RxCUI: 1655062
RxNorm name: sulfacetamide sodium 98 MG/ML Topical Foam [Ovace]
Display name: OVACE (Topical)
Full name: sulfacetamide sodium 98 MG/ML Topical Foam [Ovace]
Term type: SBD
Status: Active
Strength: 9.8%
Dose form: Foam
Route: Topical
Updated: 2026-10-17 23:58:35

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 072015
Active start: 072015
Multiple ingredient: NO
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
sulfacetamide sodium	98 MG / 1 ML	sulfacetamide	sulfacetamide sodium

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Foam	346285

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
sulfacetamide	10169

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Ovace 9.8 % Topical Foam	1	NAMES
RxNorm Name	sulfacetamide sodium 98 MG/ML Topical Foam [Ovace]	1	NAMES
RxNorm Synonym	3 linked values Ovace (sulfacetamide sodium 9.8 % ) Topical Foam Ovace 9.8 % Topical Foam Ovace 98 MG/ML Topical Foam	3	NAMES
TTY	SBD	1	ATTRIBUTES
RxCUI	1655062	1	CODES
MMSL_CODE	BD30351	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00178069601	rxnav_ndcs	yes
00178069610	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
1948a935-c938-3f05-e054-00144ff88e88	Ovace ® Plus (sodium sulfacetamide 9.8%) Foam	Mission Pharmacal Company	20210107

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	D10AF	Antiinfectives for treatment of acne	ATC1-4		sulfacetamide
ATC	S01AB	Sulfonamides	ATC1-4		sulfacetamide
FDASPL	D013449	Sulfonamides	CHEM	has_chemical_structure	sulfacetamide
FDASPL	N0000175503	Sulfonamide Antibacterial	EPC	has_epc	sulfacetamide
MEDRT	D013409	Sulfacetamide	CHEM	has_ingredient	sulfacetamide sodium
MEDRT	D013409	Sulfacetamide	CHEM	has_ingredient	sulfacetamide
MEDRT	D003320	Corneal Ulcer	DISEASE	may_treat	sulfacetamide
MEDRT	D003320	Corneal Ulcer	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D012628	Dermatitis, Seborrheic	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D012628	Dermatitis, Seborrheic	DISEASE	may_treat	sulfacetamide
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	sulfacetamide
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	sulfacetamide sodium
MEDRT	D004427	Ear Diseases	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D004427	Ear Diseases	DISEASE	may_treat	sulfacetamide
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	sulfacetamide sodium
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	sulfacetamide
MEDRT	D017192	Skin Diseases, Bacterial	DISEASE	may_treat	sulfacetamide
MEDRT	D017192	Skin Diseases, Bacterial	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D014141	Trachoma	DISEASE	may_treat	sulfacetamide
MEDRT	D014141	Trachoma	DISEASE	may_treat	sulfacetamide sodium
MEDRT	N0000009946	Para-Aminobenzoic Acid Inhibitors	MOA	has_moa	sulfacetamide
MEDRT	N0000009946	Para-Aminobenzoic Acid Inhibitors	MOA	has_moa	sulfacetamide sodium
MEDRT	N0000008344	Cellular Growth Phase Arrest	PE	has_pe	sulfacetamide
MEDRT	N0000008344	Cellular Growth Phase Arrest	PE	has_pe	sulfacetamide sodium
MEDRT	N0000008347	Cellular Synthetic Activity Alteration	PE	has_pe	sulfacetamide
MEDRT	N0000008347	Cellular Synthetic Activity Alteration	PE	has_pe	sulfacetamide sodium
MEDRT	N0000009935	Decreased Folic Acid Modification	PE	has_pe	sulfacetamide
MEDRT	N0000009935	Decreased Folic Acid Modification	PE	has_pe	sulfacetamide sodium

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Ovace	rxnav_allrelated
DF	DF	Topical Foam	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
IN	IN	sulfacetamide	rxnav_allrelated
PIN	PIN	sulfacetamide sodium	rxnav_allrelated
SBD	SBD	sulfacetamide sodium 98 MG/ML Topical Foam [Ovace]	rxnav_allrelated
SBDC	SBDC	sulfacetamide sodium 98 MG/ML [Ovace]	rxnav_allrelated
SBDF	SBDF	sulfacetamide Topical Foam [Ovace]	rxnav_allrelated
SBDFP	SBDFP	sulfacetamide sodium Topical Foam [Ovace]	rxnav_allrelated
SBDG	SBDG	Ovace Topical Product	rxnav_allrelated
SCD	SCD	sulfacetamide sodium 98 MG/ML Topical Foam	rxnav_allrelated
SCDC	SCDC	sulfacetamide sodium 98 MG/ML	rxnav_allrelated
SCDF	SCDF	sulfacetamide Topical Foam	rxnav_allrelated
SCDFP	SCDFP	sulfacetamide sodium Topical Foam	rxnav_allrelated
SCDG	SCDG	sulfacetamide Topical Product	rxnav_allrelated
SCDGP	SCDGP	sulfacetamide sodium Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	98 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
NAMES	Prescribable Synonym	Ovace 9.8 % Topical Foam
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Multum MediSource Lexicon